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Bovine Virus Diarrhea (BVD) is one of the most significant 
viral infections of cattle. BVD was first recognized as a 
disease syndrome in 1946. Today, 70 to 90 percent of the 
world's cattle population is seropositive for BVD. 1 There 
are at least two genotypes, type 1 and type 2; and two bio-
types, cytopathic and noncytopathic. Both type 1 and type 
2 genotypes have cytopathic and noncytopathic biotypes 
as members; and both type 1 and type 2 genotypes have 
many different strains, some of which are more deadly 
than others.2  Recently, the type 2 genotype has caused 
many of the most severe cases of BVD.3,1,4
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Clinical Syndromes
Most BVD virus (BVDV) 
infections are subclinical, but 
the clinical disease syndromes 
can be grouped into three 
categories:  acute BVD, in 
utero infections, and diseases 
in persistently infected (PI) 
animals.1
Acute BVD can vary 
greatly in presentation from 
fever, depression, and runny 
nose and eyes, to diarrhea to 
respiratory disease, and can 
end in complete recovery or 
death depending on several 
factors:  including, immune 
status of the animal, strain 
they are infected with, and 
age of the animal.4,1,2  BVDV 
has a profound immunosup-
pressive effect on infected 
cattle.5  Infected cattle are 
more susceptible to many 
respiratory and intestinal 
pathogens.6  BVDV also is 
an important component of 
Bovine Respiratory Disease 
Complex (BRDC).7 
In utero infections with 
BVDV can result in abortion,  
persistently infected animals, 
congenital defects, or normal, 
immuned calves8,9 depending 
on the stage of gestation the 
cow is in and her immune sta-
tus when she is infected with 
the virus. The noncytopathic 
biotype is responsible for all 
in utero infections.1  If a cow is 
infected with BVD virus in the 
first trimester of pregnancy, 
the fetus will most likely die. 
The cow will reabsorb the 
fetus, abort, or give birth to a 
mummified fetus. The abor-
tions usually are sporadic and 
at a low rate10; usually only 2 
to 7 percent in an outbreak.1   
If the cow is infected with 
BVDV between 60 and 120 
days of gestation, the calf may 
be persistently infected (PI).11  
These animals are lifelong car-
riers of BVDV and shed large 
quantities of virus in all secre-
tions throughout their lives.12 
The immune system in calves 
less than 120 days of gestation 
is not capable of responding 
properly to BVDV, therefore,  
the virus multiplies in the calf. 
When the immune system 
becomes competent the virus 
is recognized as "self," and the 
calf is "immune tolerant" to 
that strain of BVDV for life; 
it never develops an immune 
response to that strain. Infec-
tion with BVDV between 100 
and 180 days in gestation may 
result in congenital defects 
such as cerebellar hypoplasia, 
hydrocephaly, cataracts, and 
other similar defects.13  Infec-
tion of the cow in the last 
trimester of gestation, when 
the calf's immune system is 
functional, will yield a nor-
mal, immunized calf. 
Persistently infected ani-
mals can result from in utero 
infection as described above, 
or by birth from a PI dam. The 
prevalence of these cattle are 
low (0.5 to 3 percent); but their 
potential to shed large quanti-
ties of virus and infect other 
animals in the herd is tremen-
dous.14  Persistently infected 
cows always give birth to PI 
calves, and seronegative cows 
(cows that have not mounted 
an immune response to 
BVDV) are much more likely 
to give birth to PI calves. 
However, some seroposi-
tive cows can give birth to PI 
calves if their circulating anti-
bodies do not cross react with 
the virus they are exposed to. 
PI calves often are "poor do-
ers", and are more susceptible 
to other calfhood diseases due 
to the immunosuppressive 
effects of BVDV. Sometimes, 
however, PI calves may ap-
pear normal and healthy.15  PI 
calves reportedly have death 
rates of 50 percent in the first 
12 months of life.1  Some 
probably die from other calf-
hood diseases, but many die 
from BVD-Mucosal Disease 
(BVD-MD). BVD-MD occurs 
when persistently infected 
animals, harboring noncyto-
pathic BVD, are exposed to 
a cytopathic variant of BVD. 
This exposure most likely is 
due to mutation of the noncy-
topathic strain to a cytopathic 
strain.16  BVD-MD is character-
ized by profuse diarrhea with 
severe erosions and ulcers on 
all mucosal surfaces. It most 
often occurs in cattle 6 to 24 
months of age, and is nearly 
100 percent fatal.1
Transmission
BVDV rapidly loses in-
fectivity outside the host, 
and is very susceptible to 
detergents, light, temperature 
changes and other environ-
mental conditions. It is mainly 
transmitted by close contact 
with persistently infected or 
acutely infected cattle via the 
oral or nasal routes. Acutely 
infected animals only shed the 
virus for a short time (about 2 
weeks1), whereas PI animals 
shed constantly in all bodily 
secretions for life. Acutely in-
fected bulls shed virus in their 
semen for at least 2 weeks; PI 
bulls shed virus constantly 
in their semen, thus, semen 
is another potential source of 
infection in natural mating. 
Reputable artificial insemina-
tion services will check their 
bulls and semen for BVDV.2  
Sheep, goats, and pigs can 
become infected from close 
contact with cattle, and sheep 
can transmit the virus to cattle 
in close contact. Needles, 
rectal sleeves, water troughs, 
feed bunks, nose tongs, and 
other equipment can aid the 
spread of virus.2  It has been 
shown experimentally that 
biting insects can also spread 
the virus.2
Diagnosis
Diagnosis of BVD is accom-
plished by clinical signs, serol-
ogy, Virus Isolation, Fluores-
cent Antibody, or Polymerase 
Chain Reaction (PCR) tests.1  
The virus can be isolated from 
nasal swabs, serum, or tissue 
depending on the disease syn-
drome present. Diagnosis of 
BVD-Mucosal Disease is very 
important because if BVD-MD 
animals are found, the herd 
should be screened for more 
PI animals.2
Prevention
Adding persistently 
infected animals to a herd 
should be avoided as they are 
the primary method of intro-
ducing BVDV into a herd.2  
Replacement animals should 
be purchased from herds with 
accurate records of disease 
prevention and vaccination.2  
All new animals, or at least 
any small group of new ani-
mals, such as bulls,  should be 
isolated and tested for BVDV 
before entering the herd.3  
Semen should be from tested 
bulls only. If Embryo Transfer 
work is performed, all recipi-
ents should be isolated, tested 
for acute or PI BVDV, and vac-
cinated against BVDV.3
Vaccination programs are 
essential to decreasing losses 
to BVD. The goal of any vac-
cination program is to prevent 
fetal infection and increase 
colostral immunity. This may 
not always work, depending 
on the strain of vaccine and 
the field strain, but it is the 
best weapon currently avail-
able.3  Vaccination does not 
clear persistent infections 
from a herd3,5 but the virus 
does not spread as quickly 
through a vaccinated herd.3,6 
The two types of vac-
cine available are modified 
live and inactivated (killed), 
and controversy exists over 
which is better. Modified live 
vaccines (MLV) offer more 
cross-protection against differ-
ent strains and the immunity 
conferred by them is longer 
lasting and stronger.3  Modi-
fied live vaccines should be 
used with caution, however, 
as they may cause immu-
nosuppression, fetal infec-
tion4, or revert to virulence.1 
Inactivated vaccines are not 
immunosuppressive, do not 
infect feti, and have minimal 
risk. However, the immune 
response they generate is 
weaker, of shorter duration, 
and may not cross-protect as 
well as MLV.4  Cattle receiving 
inactivated vaccine must also 
have a booster 3 to 4 weeks 
after the first vaccination.4  
Neither MLV nor inactivated 
vaccines give lifelong protec-
tion, and yearly boosters are 
required with both.4
There is no one vaccination 
program for all situations. 
Producers should consult 
their veterinarian for a pro-
gram tailored to their herd.
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